X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE IPCA LABS TTK HEALTHCARE/
IPCA LABS
 
P/E (TTM) x 51.5 41.9 122.9% View Chart
P/BV x 9.5 3.2 295.2% View Chart
Dividend Yield % 0.3 0.2 191.5%  

Financials

 TTK HEALTHCARE   IPCA LABS
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
IPCA LABS
Mar-17
TTK HEALTHCARE/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs663643 103.2%   
Low Rs399503 79.4%   
Sales per share (Unadj.) Rs535.6254.4 210.5%  
Earnings per share (Unadj.) Rs15.916.1 99.2%  
Cash flow per share (Unadj.) Rs20.029.8 67.3%  
Dividends per share (Unadj.) Rs4.001.00 400.0%  
Dividend yield (eoy) %0.80.2 431.4%  
Book value per share (Unadj.) Rs137.6194.6 70.7%  
Shares outstanding (eoy) m7.77126.20 6.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.02.3 44.0%   
Avg P/E ratio x33.335.7 93.4%  
P/CF ratio (eoy) x26.519.2 137.9%  
Price / Book Value ratio x3.92.9 131.1%  
Dividend payout %25.16.2 403.1%   
Avg Mkt Cap Rs m4,12772,300 5.7%   
No. of employees `0001.713.3 12.8%   
Total wages/salary Rs m6076,960 8.7%   
Avg. sales/employee Rs Th2,436.72,413.5 101.0%   
Avg. wages/employee Rs Th355.2523.2 67.9%   
Avg. net profit/employee Rs Th72.5152.4 47.6%   
INCOME DATA
Net Sales Rs m4,16232,106 13.0%  
Other income Rs m61226 27.1%   
Total revenues Rs m4,22332,332 13.1%   
Gross profit Rs m1974,448 4.4%  
Depreciation Rs m321,730 1.8%   
Interest Rs m30241 12.4%   
Profit before tax Rs m1972,703 7.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73675 10.8%   
Profit after tax Rs m1242,028 6.1%  
Gross profit margin %4.713.9 34.2%  
Effective tax rate %37.025.0 148.2%   
Net profit margin %3.06.3 47.1%  
BALANCE SHEET DATA
Current assets Rs m1,62917,340 9.4%   
Current liabilities Rs m1,0589,559 11.1%   
Net working cap to sales %13.724.2 56.6%  
Current ratio x1.51.8 84.9%  
Inventory Days Days30100 29.7%  
Debtors Days Days3457 59.1%  
Net fixed assets Rs m55620,779 2.7%   
Share capital Rs m78252 30.8%   
"Free" reserves Rs m87824,499 3.6%   
Net worth Rs m1,06924,553 4.4%   
Long term debt Rs m1593,517 4.5%   
Total assets Rs m2,39939,595 6.1%  
Interest coverage x7.612.2 62.0%   
Debt to equity ratio x0.10.1 103.6%  
Sales to assets ratio x1.70.8 213.9%   
Return on assets %6.45.7 111.9%  
Return on equity %11.68.3 140.3%  
Return on capital %18.510.5 175.9%  
Exports to sales %0.848.6 1.6%   
Imports to sales %1.414.2 9.8%   
Exports (fob) Rs m3315,617 0.2%   
Imports (cif) Rs m584,571 1.3%   
Fx inflow Rs m3315,617 0.2%   
Fx outflow Rs m635,828 1.1%   
Net fx Rs m-309,790 -0.3%   
CASH FLOW
From Operations Rs m1272,764 4.6%  
From Investments Rs m-146-1,432 10.2%  
From Financial Activity Rs m22-1,591 -1.4%  
Net Cashflow Rs m3-259 -1.0%  

Share Holding

Indian Promoters % 65.4 45.9 142.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 11.4 32.5%  
FIIs % 5.2 25.3 20.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.4 148.3%  
Shareholders   12,723 36,892 34.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   FDC LTD.  ALEMBIC LTD  WYETH LTD  ELDER PHARMA  SUVEN LIFE  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 16, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - SUN PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS